CONFORTINI; Donatella

Patent Applications and Registrations

Patent applications and USPTO patent grants for CONFORTINI; Donatella.The latest application filed is for "polymorphic forms alpha, beta and gamma of rifaximin".

Company Profile

12.25.47

CONFORTINI; Donatella - Bologna IT
CONFORTINI; Donatella - CALDERARA IT
Confortini; Donatella - Calderara di Reno IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20220127283 - VISCOMI; Giuseppe Claudio ; et al.	2022-04-28
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20220119403 - VISCOMI; Giuseppe Claudio ; et al.	2022-04-21
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20220119410 - VISCOMI; Giuseppe Claudio ; et al.	2022-04-21
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20200339599 - VISCOMI; Giuseppe Claudio ; et al.	2020-10-29
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20200339600 - VISCOMI; Giuseppe Claudio ; et al.	2020-10-29
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20200277301 - VISCOMI; Giuseppe Claudio ; et al.	2020-09-03
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Grant 10,703,763 - Viscomi , et al.	2020-07-07
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20200002350 - VISCOMI; Giuseppe Claudio ; et al.	2020-01-02
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20190263829 - VISCOMI; Giuseppe Claudio ; et al.	2019-08-29
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20190263830 - VISCOMI; Giuseppe Claudio ; et al.	2019-08-29
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20190135830 - VISCOMI; Giuseppe Claudio ; et al.	2019-05-09
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20190135831 - VISCOMI; Giuseppe Claudio ; et al.	2019-05-09
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20180291032 - VISCOMI; Giuseppe Claudio ; et al.	2018-10-11
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20180065987 - VISCOMI; Giuseppe Claudio ; et al.	2018-03-08
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20180065988 - VISCOMI; Giuseppe Claudio ; et al.	2018-03-08
Rifaximin derivative and uses thereof Grant 9,725,466 - Golden , et al. August 8, 2	2017-08-08
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20170210757 - VISCOMI; Giuseppe Claudio ; et al.	2017-07-27
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20170210758 - VISCOMI; Giuseppe Claudio ; et al.	2017-07-27
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20160362419 - VISCOMI; Giuseppe Claudio ; et al.	2016-12-15
Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect Grant 9,498,442 - Viscomi , et al. November 22, 2	2016-11-22
Rifaximin Derivative And Uses Thereof App 20160257700 - Golden; Pam ; et al.	2016-09-08
Rifaximin derivative and uses thereof Grant 9,364,467 - Golden , et al. June 14, 2	2016-06-14
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Grant 9,271,968 - Viscomi , et al. March 1, 2	2016-03-01
Rifaximin Derivative And Uses Thereof App 20150342934 - Golden; Pam ; et al.	2015-12-03
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20150182508 - VISCOMI; Giuseppe Claudio ; et al.	2015-07-02
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20150175627 - VISCOMI; Giuseppe Claudio ; et al.	2015-06-25
Rifaximin derivative and uses thereof Grant 9,035,046 - Golden , et al. May 19, 2	2015-05-19
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20150073007 - VISCOMI; Giuseppe Claudio ; et al.	2015-03-12
Rifaximin Derivative And Uses Thereof App 20140378495 - Golden; Pam ; et al.	2014-12-25
Pharmaceutical compositions comprising polymorphic forms .alpha., .beta., and .gamma. of rifaximin Grant 8,853,231 - Viscomi , et al. October 7, 2	2014-10-07
Polymorphic forms .alpha., .beta. and .gamma. of rifaximin Grant 8,835,452 - Viscomi , et al. September 16, 2	2014-09-16
Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect Grant 8,748,447 - Viscomi , et al. June 10, 2	2014-06-10
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Grant 8,741,904 - Viscomi , et al. June 3, 2	2014-06-03
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20130310410 - Viscomi; Giuseppe Claudio ; et al.	2013-11-21
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20130289269 - Viscomi; Giuseppe Claudio ; et al.	2013-10-31
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20130281697 - Viscomi; Giuseppe Claudio ; et al.	2013-10-24
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Grant 8,518,949 - Viscomi , et al. August 27, 2	2013-08-27
Use of polymorphic forms of rifaximin for medical preparations Grant 8,404,704 - Viscomi , et al. March 26, 2	2013-03-26
Rifaximin Powder, Process For Preparing The Same And Controlled Release Compositions Containing Said Rifaximin Useful For Obtaining A Long-lasting Effect App 20130004576 - Viscomi; Giuseppe Claudio ; et al.	2013-01-03
Rifaximin Compositions And Method Of Use App 20120258166 - Viscomi; Giuseppe Claudio ; et al.	2012-10-11
Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations App 20120245355 - VISCOMI; Giuseppe Claudio ; et al.	2012-09-27
Processes For The Production Of Polymorphic Forms Of Rifaximin App 20120214989 - Viscomi; Giuseppe Claudio ; et al.	2012-08-23
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20120203000 - Viscomi; Giuseppe Claudio ; et al.	2012-08-09
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20120202989 - Viscomi; Giuseppe Claudio ; et al.	2012-08-09
Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations Grant 8,193,196 - Viscomi , et al. June 5, 2	2012-06-05
Processes for the production of polymorphic forms of rifaximin Grant 8,173,801 - Viscomi , et al. May 8, 2	2012-05-08
Pharmaceutical compositions comprising polymorphic forms .alpha., .beta., and .gamma. of rifaximin Grant 8,158,644 - Viscomi , et al. April 17, 2	2012-04-17
Polymorphic forms .alpha., .beta. and .gamma. of rifaximin Grant 8,158,781 - Viscomi , et al. April 17, 2	2012-04-17
Use Of Polymorphic Forms Of Rifaximin For Medical Preparations App 20120059023 - Viscomi; Giuseppe C. ; et al.	2012-03-08
Rifaximin Compositions And Method Of Use App 20120035202 - Viscomi; Giuseppe Claudio ; et al.	2012-02-09
Processes For The Production Of Polymorphic Forms Of Rifaximin App 20110160449 - Viscomi; Giuseppe Claudio ; et al.	2011-06-30
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20110160448 - Viscomi; Giuseppe Claudio ; et al.	2011-06-30
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20110152516 - Viscomi; Giuseppe Claudio ; et al.	2011-06-23
Rifaximin Compositions And Method Of Use App 20110086871 - VISCOMI; Giuseppe Claudio ; et al.	2011-04-14
Processes for the production of polymorphic forms of rifaximin Grant 7,923,553 - Viscomi , et al. April 12, 2	2011-04-12
Use of polymorphic forms of rifaximin for medical preparations Grant 7,915,275 - Viscomi , et al. March 29, 2	2011-03-29
Pharmaceutical compositions comprising polymorphic forms .alpha., .beta., and .gamma. of rifaximin Grant 7,906,542 - Viscomi , et al. March 15, 2	2011-03-15
Polymorphic forms .alpha., .beta. and .gamma. of rifaximin Grant 7,902,206 - Viscomi , et al. March 8, 2	2011-03-08
Polymorphic forms .alpha., .beta., and .gamma. of rifaximin Grant 7,612,199 - Viscomi , et al. November 3, 2	2009-11-03
Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20090234114 - VISCOMI; Guiseppe Glaudio ; et al.	2009-09-17
polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations App 20090130201 - Viscomi; Giuseppe Claudio ; et al.	2009-05-21
Polymorphic Forms Alpha, Beta And Gamma Of Rifaximin App 20080262220 - Viscomi; Giuseppe Claudio ; et al.	2008-10-23
Processes For The Production Of Polymorphic Forms Of Rifaximin App 20080262232 - Viscomi; Giuseppe Claudio ; et al.	2008-10-23
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, And Gamma Of Rifaximin App 20080262012 - Viscomi; Giuseppe Claudio ; et al.	2008-10-23
Rifaximin Compositions And Method Of Use App 20080262024 - Viscomi; Giuseppe Claudio ; et al.	2008-10-23
Use of polymorphic forms of rifaximin for medical preparations App 20080132530 - Viscomi; Giuseppe C. ; et al.	2008-06-05
Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations Grant 7,045,620 - Viscomi , et al. May 16, 2	2006-05-16
Polymorphic forms of rifaximin, processes for their production and uses thereof App 20050272754 - Viscomi, Giuseppe C. ; et al.	2005-12-08
Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations App 20050101598 - Viscomi, Giuseppe C. ; et al.	2005-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.